Sarah Watson
Edinburgh Napier University(GB)Bridge University(SS)
Publications by Year
Research Areas
Pharmacovigilance and Adverse Drug Reactions, COVID-19 Clinical Research Studies, Liver Disease and Transplantation, Meta-analysis and systematic reviews, Organ Transplantation Techniques and Outcomes
Most-Cited Works
- → Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies(2010)594 cited
- → Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease(2016)540 cited
- → Reported adverse drug reactions in women and men: Aggregated evidence from globally collected individual case reports during half a century(2019)297 cited
- → Improved Statistical Signal Detection in Pharmacovigilance by Combining Multiple Strength-of-Evidence Aspects in vigiRank(2014)108 cited
- → Safety Concerns Reported by Patients Identified in a Collaborative Signal Detection Workshop using VigiBase: Results and Reflections from Lareb and Uppsala Monitoring Centre(2017)55 cited
- → Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports(2020)40 cited
- → vigiRank for statistical signal detection in pharmacovigilance: First results from prospective real‐world use(2017)29 cited
- → Sex Differences in Reported Adverse Drug Reactions to Angiotensin-Converting Enzyme Inhibitors(2022)24 cited
- → Resuming liver transplantation amid the COVID-19 pandemic(2020)20 cited
- → Longitudinal medical records as a complement to routine drug safety signal analysis(2015)19 cited